Both in Pharmaceuticals
Altimmune vs Relmada Therapeutics
Over the past year ALT returned −49.6% and RLMD returned +58.4%; their daily moves had a correlation of 0.18.
ALT −49.6% RLMD +58.4%Growth of $1, one year, split-adjusted
| Metric | ALT | RLMD |
|---|---|---|
| Price | $2.04 | $3.58 |
| Market cap | $396.8M | $381.9M |
| Today | −4.67% | +4.07% |
| 1 month | −26.1% | −2.2% |
| 6 months | −27.7% | −53.1% |
| Year to date | −43.5% | −25.9% |
| 1 year | −49.0% | +46.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 12,800.5× | — |
| Net cash | $291.5M | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.2% | 58.2% |
| Short % of float | 22.2% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).